The neoplastic potential of columnar-lined (Barrett's) esophagus
- PMID: 1561815
- DOI: 10.1007/BF02071538
The neoplastic potential of columnar-lined (Barrett's) esophagus
Abstract
Reflux of gastric contents is the most important factor contributing to the development of a columnar-lined esophagus (CLE). CLE should be considered a "mosaic" of cells, glands, and architectural types showing variable degrees of maturation towards intestinal and gastric epithelium. Dysplasia refers to an unequivocally neoplastic alteration in the epithelium. High-grade (severe) dysplasia consists of neoplastic cellular and/or architectural changes within the columnar epithelium, without invasion through the basement membrane. The prevalence of dysplasia is usually 5% to 10%. Dysplasia has been found in the vast majority in the specialized columnar-type or intestinal-type epithelium. Adenocarcinoma in CLE is most often seen in males. At the time of diagnosis transmural tumor infiltration is found in 60% to 88% of patients, and lymph node invasion in 55% to 74% of patients. The prognosis is poor with a low 5 year survival. Estimates of incidence of cancer vary from 1 case per 52 patients years of follow-up to 1 case per 441 patient years of follow-up.
Similar articles
-
The diagnosis and management of Barrett's esophagus.Adv Surg. 1999;33:29-68. Adv Surg. 1999. PMID: 10572561 Review.
-
Review on novel concepts of columnar lined esophagus.Wien Klin Wochenschr. 2013 Oct;125(19-20):577-90. doi: 10.1007/s00508-013-0418-z. Epub 2013 Sep 6. Wien Klin Wochenschr. 2013. PMID: 24061694 Review.
-
Pathogenesis of columnar-lined esophagus.World J Gastroenterol. 2006 Mar 14;12(10):1521-8. doi: 10.3748/wjg.v12.i10.1521. World J Gastroenterol. 2006. PMID: 16570343 Free PMC article. Review.
-
Gastroesophageal reflux and cancer.Thorac Surg Clin. 2005 Aug;15(3):341-52. doi: 10.1016/j.thorsurg.2005.03.003. Thorac Surg Clin. 2005. PMID: 16104125 Review.
-
Recurrent columnar-lined esophageal segments--study of the phenotypic characteristics using intestinal markers.Dis Esophagus. 2002;15(4):282-6. doi: 10.1046/j.1442-2050.2002.00264.x. Dis Esophagus. 2002. PMID: 12472472
Cited by
-
Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia.Langenbecks Arch Surg. 2003 Apr;388(2):83-7. doi: 10.1007/s00423-002-0343-5. Epub 2003 Feb 20. Langenbecks Arch Surg. 2003. PMID: 12712340 Review.
-
Adenosquamous carcinoma arising in Barrett's esophagus.Jpn J Thorac Cardiovasc Surg. 2002 Dec;50(12):537-40. doi: 10.1007/BF02913171. Jpn J Thorac Cardiovasc Surg. 2002. PMID: 12561099 Review.
-
c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.J Clin Pathol. 1995 Feb;48(2):129-32. doi: 10.1136/jcp.48.2.129. J Clin Pathol. 1995. PMID: 7745111 Free PMC article.
-
Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence.Gut. 1994 Jun;35(6):764-8. doi: 10.1136/gut.35.6.764. Gut. 1994. PMID: 8020801 Free PMC article.
-
The surgery of complicated gastro-oesophageal reflux.Ir J Med Sci. 1996 Jul-Sep;165(3):193-9. doi: 10.1007/BF02940250. Ir J Med Sci. 1996. PMID: 8824026 Review. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Medical